Denne siden ble automatisk oversatt og nøyaktigheten av oversettelsen er ikke garantert. Vennligst referer til engelsk versjon for en kildetekst.

Ernæringsoptimalisering og fellesskapsløft for gjenoppretting etter fødsel (NOURISH-GDM)

17. september 2026 oppdatert av: Johns Hopkins University

Ernæringsoptimalisering og fellesskapsløft for gjenoppretting etter fødsel: Intervensjoner for å støtte helbredelse etter svangerskapsdiabetes

The goal of this clinical trial is to better understand how different strategies, timing, and enhancements to medically tailored food delivery will address structural inequities in the food environment, empower communities to sustain behavior change, and ultimately improve postpartum weight control to prevent type 2 diabetes-a potent contributor to disparate mortality among Black women.

The main aims of the study are:

  • To conduct a pilot randomized control trial to test the feasibility, acceptability, and effectiveness of a multi-component Medically Tailored Food (MTF) intervention, Moveable Feast ENHANCED (a hybrid MTF intervention with a patient-activated change from prepared meals to fresh food delivery, customized for postpartum people, culturally customized for engagement and adherence, and food provision for dependents) versus MFeast Usual Care (prepared medically tailored foods only)
  • To test sustainability and scalability.

Participants will:

  • Respond to online surveys (supported by study team members via scheduled phone calls) via REDCap links shared before each study visit at baseline, 3, 6 months post-delivery after the baseline survey.
  • Submit anthropometric data (i.e, weight) and information about laboratory results ( e.g. HgbA1C)

Studieoversikt

Detaljert beskrivelse

This study will evaluate the feasibility, acceptability, and preliminary effectiveness of a postpartum dietary intervention for Black women with obesity and a recent pregnancy complicated by gestational diabetes mellitus (GDM). The investigators will recruit women through Medicaid insurance plans (Priority Partners), clinical obstetric practice (Johns Hopkins Outpatient Center, Women's Health Center), perinatal community-based organizations (MOM Cares and Bloom Collective), and home-visiting locations (The Family Tree of Maryland)-all of which can verify clinical outcomes for participants.

At 37 weeks gestation, participants are contacted by the study team for consent, baseline data collection (baseline visit 1), and randomization 1:1 to receive the intervention vs. usual care (which begins in the first postpartum week). 3-7 days after randomization, the remainder of baseline visit information (baseline visit 2) is collected including information for the prepared MTF vendor (Moveable Feast Baltimore)

The intervention group will initially receive prepared MTF (low carbohydrate, and low-fat meals, which have been shown to improve glycemia in people with prediabetes) delivered by Moveable Feast (MFeast) (10 meals weekly; Tailored Medical Nutrition Therapy (MNT) delivered by dieticians from MFeast via monthly phone calls and focused on two high yield topics only: ↓sugar-sweetened beverages and ↑ fruit and vegetable consumption; Lactation nutritional snack bundles to boost milk supply + structural support for breastfeeding/ pumping via lactation consultants and pumping supply subsidization; culturally-adapted seasoning bundles; and dependent meal boxes for children in the household (i.e., will include 10 developmentally appropriate snack and small meal bundles, for up to 24 weeks. At postpartum week 8, participants will be offered a transition from prepared medically tailored meals to Instacart fresh food delivery (medically tailored via study team-crafted virtual grocery store) for 16 more weeks.

Those assigned to the "MFeast Usual Care" group will receive prepared MTF delivered by MFeast and as-needed MNT from 1 to 24 weeks postpartum.

Studietype

Intervensjonell

Registrering (Antatt)

40

Fase

  • Ikke aktuelt

Kontakter og plasseringer

Denne delen inneholder kontaktinformasjon for de som utfører studien, og informasjon om hvor denne studien blir utført.

Studiekontakt

  • Navn: Michelle S Ogunwole, MD PhD
  • Telefonnummer: 2143154936
  • E-post: sogunwo1@jhmi.edu

Studiesteder

    • Maryland
      • Baltimore, Maryland, Forente stater, 21205
        • Rekruttering
        • East Baltimore Medical Campus

Deltakelseskriterier

Forskere ser etter personer som passer til en bestemt beskrivelse, kalt kvalifikasjonskriterier. Noen eksempler på disse kriteriene er en persons generelle helsetilstand eller tidligere behandlinger.

Kvalifikasjonskriterier

Alder som er kvalifisert for studier

18 år og eldre (Voksen, Eldre voksen)

Tar imot friske frivillige

Nei

Kjønn som er kvalifisert for studier

Hunn

Beskrivelse

Inclusion Criteria:

  • Age ≥18 years
  • Self-identify as Black or African American
  • Low-income (defined as eligible for Special Supplemental Nutrition Program for Women, Infants, and Children (WIC) benefits)
  • Speak English as a primary language
  • Identify as a primary meal planner/preparer
  • Gestational diabetes
  • Gestational age >37 weeks
  • Have a BMI > 30 (calculated based on chart review of height and weight measurement)
  • Willing to take part in the intervention and data collection procedures through online surveys

Exclusion Criteria:

  • Mothers who have social support i.e. have family members preparing meals for the mother
  • Mothers who are unlikely to be at the primary residence in the postpartum period
  • Mothers with very specific dietary needs, i.e, food allergies, picky eaters, vegetarian / vegan
  • Mothers whose birth outcome is a stillborn
  • Mothers who have serious mental illness

Studieplan

Denne delen gir detaljer om studieplanen, inkludert hvordan studien er utformet og hva studien måler.

Hvordan er studiet utformet?

Designdetaljer

  • Primært formål: Forebygging
  • Tildeling: Randomisert
  • Intervensjonsmodell: Parallell tildeling
  • Masking: Enkelt

Våpen og intervensjoner

Deltakergruppe / Arm
Intervensjon / Behandling
Eksperimentell: MFeast ENHANCED

MFeast ENHANCED (a hybrid MTF intervention with a patient-activated transition from prepared meal to fresh food delivery, adaptations for postpartum people, structural and nutritional lactation support, cultural adaptations for engagement and adherence, and food provision for dependents)

Intervention group will initially receive prepared MTF (low carbohydrate, low-fat meals, which have been shown to improve glycemia in people with prediabetes) delivered by MFeast (10 meals weekly); Tailored Medical Nutrition Therapy (MNT) delivered by dieticians from MFeast via monthly phone calls and focused on only: ↓sugar-sweetened beverages and ↑fruit and vegetable consumption; Lactation snack bundles to boost milk supply + structural support for breastfeeding/pumping via lactation consultants and pumping supply subsidization; culturally-adapted seasoning bundles; and dependent meal boxes for children in the household (i.e., will include 10 developmentally appropriate snack and small meal bundles, for up to 24 weeks. At postpartum week 8 participants will be offered a transition from prepared medically tailored meals to Instacart fresh food delivery (via study team-crafted virtual grocery store) for 16 more weeks.

Aktiv komparator: MFeast Usual Care

MFeast Usual Care (prepared medically tailored meals only).

Those assigned to the "MFeast Usual Care" group will receive prepared MTF delivered by MFeast and as needed MNT from 1 to 24 weeks postpartum.

Hva måler studien?

Primære resultatmål

Resultatmål
Tiltaksbeskrivelse
Tidsramme
Participant Enrollment Rate
Tidsramme: 6-8 months postpartum

Participant Enrollment Rate as assessed by the percentage of participants consented/enrolled compared to the total eligible participants

6-8 months postpartum
Participant Retention
Tidsramme: 6-8 months postpartum

Retention as assessed by the percentage of participants completing all study follow-up visits among all enrolled participants.

6-8 months postpartum
Adherence as assessed by self-reported food consumption scores and photographs sent to the study team via secure messaging app
Tidsramme: 6-8 months postpartum

Consumption scores range from 0%, 25%, 50%, 75%, or 100%, indicating the amount of food consumed the prior week (self and dependents scores reported).

6-8 months postpartum
Satisfaction as assessed by focus groups and the 8 item Client Satisfaction Questionnaire- (CSQ-8)
Tidsramme: 6-8 months postpartum

Participants rate satisfaction with the intervention's meal quality, delivery service, and likelihood of recommending the service to others at study completion, to assess the extent to which the intervention met their needs and preferences. Scores range from 8 to 32, with higher values indicating higher satisfaction.

6-8 months postpartum
Participant Engagement assessed by frequency and quality of meal discussions
Tidsramme: 1-6 months postpartum

Analyze the messaging app and Slack Channel to determine the frequency and quality of discussions about meals and recipes.

1-6 months postpartum

Sekundære resultatmål

Resultatmål
Tiltaksbeskrivelse
Tidsramme
Dietary Quality as assessed by the Healthy Eating Index (HEI) 24-hour recall
Tidsramme: Baseline, 3 and 6 months postpartum

The HEI uses a scoring system to evaluate a set of foods. The scores range from 0 to 100. An ideal overall HEI score of 100 reflects that the set of foods aligns with key dietary recommendations and dietary patterns published in the Dietary Guidelines.

Baseline, 3 and 6 months postpartum
Stress assessed by the 4-item Stress Scale.
Tidsramme: Baseline, 3 and 6 months postpartum

The 4-item Stress Scale consists of 4 questions. The lowest total score is 0 and the highest total score on the scale is 16. Higher scores are correlated to more stress.

Baseline, 3 and 6 months postpartum
Food Insecurity measured using a 6-item Food Insecurity scale.
Tidsramme: Baseline, 3 and 6 months postpartum

The 6-item Food Insecurity scale uses a subset of the standard 18 item food security scale. The Scores on the scale range from 0-6 with 0-1 indicating high or marginal food security, 2-4 indicating low food security and 5-6 indicating very low food security

Baseline, 3 and 6 months postpartum
Postpartum Weight Retention in pounds as assessed by the difference in self-reported pre-pregnancy weight and postpartum weights
Tidsramme: Baseline, 3 and 6 months postpartum

Will be assessed by calculating the difference in self reported pre-pregnancy weight (with Electronic Health Record validation) and postpartum weights (study provided scales)

Baseline, 3 and 6 months postpartum

Andre resultatmål

Resultatmål
Tiltaksbeskrivelse
Tidsramme
2 hour plasma glucose levels assessed using Oral Glucose Tolerance Test (OGTT)
Tidsramme: 4-12 weeks postpartum

Test will be done using 75 g oral glucose load with measurement of 2-hour plasma glucose levels. Obtained by electronic health records (EHR) or lab request.

4-12 weeks postpartum
HbA1C
Tidsramme: 3 and 6 months postpartum

HbA1C assessed by EHR or lab request

3 and 6 months postpartum
Percent time spent in euglycemia as assessed by participant blinded Continuous Glucose Monitor (CGM) sensor
Tidsramme: 3 and 6 months postpartum

Will be measured by % time in euglycemia (glucose 70-139)

3 and 6 months postpartum
Percent time spent in hyperglycemia assessed by participant blinded CGM sensor
Tidsramme: 3 and 6 months postpartum

Will be measured by % time with hyperglycemia (glucose >140)

3 and 6 months postpartum
Postprandial glucose excursions assessed by participant blinded CGM sensor
Tidsramme: 3 and 6 months postpartum

Postprandial glucose is calculated using the incremental area under the curve (AUCi) of blood glucose (mg/dL) over a period of time. The AUCi will be calculated for 1 hour (AUCi 0-60) after a meal. The participants will have the sensors on for 10 days, and will be asked to document their meals to correlate with calculated AUCi's.

3 and 6 months postpartum
Mean daily glucose
Tidsramme: 3 and 6 months postpartum

Mean daily glucose for 10 days in months 3 and 6 postpartum

3 and 6 months postpartum

Samarbeidspartnere og etterforskere

Det er her du vil finne personer og organisasjoner som er involvert i denne studien.

Etterforskere

  • Hovedetterforsker: Michelle S Ogunwole, MD, PhD, Johns Hopkins School of Medicine

Studierekorddatoer

Disse datoene sporer fremdriften for innsending av studieposter og sammendragsresultater til ClinicalTrials.gov. Studieposter og rapporterte resultater gjennomgås av National Library of Medicine (NLM) for å sikre at de oppfyller spesifikke kvalitetskontrollstandarder før de legges ut på det offentlige nettstedet.

Studer hoveddatoer

Studiestart (Faktiske)

15. september 2025

Primær fullføring (Antatt)

1. mars 2027

Studiet fullført (Antatt)

1. juni 2027

Datoer for studieregistrering

Først innsendt

31. mai 2024

Først innsendt som oppfylte QC-kriteriene

31. mai 2024

Først lagt ut (Faktiske)

6. juni 2024

Oppdateringer av studieposter

Sist oppdatering lagt ut (Faktiske)

22. september 2026

Siste oppdatering sendt inn som oppfylte QC-kriteriene

17. september 2026

Sist bekreftet

1. september 2026

Mer informasjon

Begreper knyttet til denne studien

Legemiddel- og utstyrsinformasjon, studiedokumenter

Studerer et amerikansk FDA-regulert medikamentprodukt

Nei

Studerer et amerikansk FDA-regulert enhetsprodukt

Nei

Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .

Abonnere